JPMorgan Chase & Co’s Serina Therapeutics SER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55 | Sell |
9
-3
| -25% | -$18 | ﹤0.01% | 6001 |
|
|
2025
Q1 | $68 | Sell |
12
-1
| -8% | -$6 | ﹤0.01% | 6051 |
|
|
2024
Q4 | $65 | Hold |
13
| – | – | ﹤0.01% | 6024 |
|
|
2024
Q3 | $87 | Buy |
13
+2
| +18% | +$13 | ﹤0.01% | 5951 |
|
|
2024
Q2 | $105 | Buy |
11
+10
| +1,000% | +$95 | ﹤0.01% | 5859 |
|
|
2024
Q1 | $13 | Sell |
1
-57
| -98% | -$741 | ﹤0.01% | 6200 |
|
|
2023
Q4 | $790 | Hold |
58
| – | – | ﹤0.01% | 5829 |
|
|
2023
Q3 | $1.39K | Buy |
58
+1
| +2% | +$24 | ﹤0.01% | 5644 |
|
|
2023
Q2 | $1.8K | Buy |
+57
| New | +$1.8K | ﹤0.01% | 5450 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 6161 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 5982 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 5871 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 5947 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 5981 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 5946 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5791 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 5672 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5410 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5126 |
|
|
2020
Q3 | – | Sell |
-10
| Closed | – | – | 5053 |
|
|
2020
Q2 | $0 | Sell |
10
-981
| -99% | – | ﹤0.01% | 4989 |
|
|
2020
Q1 | $32K | Buy |
991
+196
| +25% | +$6.33K | ﹤0.01% | 4257 |
|
|
2019
Q4 | $51K | Buy |
795
+597
| +302% | +$38.3K | ﹤0.01% | 4234 |
|
|
2019
Q3 | $14K | Buy |
198
+32
| +19% | +$2.26K | ﹤0.01% | 4531 |
|
|
2019
Q2 | $21K | Sell |
166
-16
| -9% | -$2.02K | ﹤0.01% | 4509 |
|
|
2019
Q1 | $26K | Buy |
182
+108
| +146% | +$15.4K | ﹤0.01% | 4441 |
|
|
2018
Q4 | $8K | Buy |
+74
| New | +$8K | ﹤0.01% | 4650 |
|